Assessing ETA Violations, and Selecting Attainable/Realistic Parameters Causal Effect/Variable Importance Estimation and the Experimental Treatment Assumption.

Slides:



Advertisements
Similar presentations
Agency for Healthcare Research and Quality (AHRQ)
Advertisements

Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Controlling for Time Dependent Confounding Using Marginal Structural Models in the Case of a Continuous Treatment O Wang 1, T McMullan 2 1 Amgen, Thousand.
A workshop introducing doubly robust estimation of treatment effects
Evidence Based Advertising “Don’t accept your dog’s admiration as conclusive evidence that you are wonderful” -Ann Landers.
Lecture 28 Categorical variables: –Review of slides from lecture 27 (reprint of lecture 27 categorical variables slides with typos corrected) –Practice.
LSU-HSC School of Public Health Biostatistics 1 Statistical Core Didactic Introduction to Biostatistics Donald E. Mercante, PhD.
Estimating Direct Effects of New HIV Prevention Methods. Focus: the MIRA Trial UCSF: Helen Cheng, Nancy Padian, Steve Shiboski, Ariane van der Straten.
Correlation and regression Dr. Ghada Abo-Zaid
HSRP 734: Advanced Statistical Methods July 24, 2008.
Informative Censoring Addressing Bias in Effect Estimates Due to Study Drop-out Mark van der Laan and Maya Petersen Division of Biostatistics, University.
What is a sample? Epidemiology matters: a new introduction to methodological foundations Chapter 4.
Confidence Intervals © Scott Evans, Ph.D..
When Is Stratification Detrimental to a Clinical Trial Design? Part II Katherine L. Monti, Ph.D. Senior Statistical Scientist and Director of the Massachusetts.
 Confounders are usually controlled with the “standard” response regression model.  The standard model includes confounders as covariates in the response.
Concept of Measurement
Common Problems in Writing Statistical Plan of Clinical Trial Protocol Liying XU CCTER CUHK.
Non-Experimental designs: Developmental designs & Small-N designs
Sampling and Experimental Control Goals of clinical research is to make generalizations beyond the individual studied to others with similar conditions.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Cohort Studies.
Chapter 9 Hypothesis Testing II. Chapter Outline  Introduction  Hypothesis Testing with Sample Means (Large Samples)  Hypothesis Testing with Sample.
Today Concepts underlying inferential statistics
Part 3 of 3 By: Danielle Davidov, PhD & Steve Davis, MSW, MPA INTRODUCTION TO RESEARCH: SAMPLING & DESIGN.
“FUTURE CONSIDERATIONS FOR PK/PD RESEARCH” Terrence F. Blaschke, M.D. Professor of Medicine and Molecular Pharmacology Stanford University.
Association vs. Causation
Chapter 12 Inferential Statistics Gay, Mills, and Airasian
Choosing Statistical Procedures
1. Statistics: Learning from Samples about Populations Inference 1: Confidence Intervals What does the 95% CI really mean? Inference 2: Hypothesis Tests.
Chapter 4 Hypothesis Testing, Power, and Control: A Review of the Basics.
Understanding Statistics
Sample Size Determination Donna McClish. Issues in sample size determination Sample size formulas depend on –Study design –Outcome measure Dichotomous.
Chapter 9 Hypothesis Testing II: two samples Test of significance for sample means (large samples) The difference between “statistical significance” and.
Review of Chapters 1- 5 We review some important themes from the first 5 chapters 1.Introduction Statistics- Set of methods for collecting/analyzing data.
 Is there a comparison? ◦ Are the groups really comparable?  Are the differences being reported real? ◦ Are they worth reporting? ◦ How much confidence.
Experimental Design making causal inferences Richard Lambert, Ph.D.
Experimental Design All experiments have independent variables, dependent variables, and experimental units. Independent variable. An independent.
Targeted MLE for Variable Importance and Causal Effect with Clinical Trial and Observational Data Mark van der Laan works.bepress.com/mark_van_der_laan.
Alec Walker September 2014 Core Characteristics of Randomized Clinical Trials.
1 An Interim Monitoring Approach for a Small Sample Size Incidence Density Problem By: Shane Rosanbalm Co-author: Dennis Wallace.
1 1 Using Marginal Structural Model to Estimate and Adjust for Causal Effect of Post- discontinuation Chemotherapy on Survival in Cancer Trials Y. Wang,
Chapter 4 Linear Regression 1. Introduction Managerial decisions are often based on the relationship between two or more variables. For example, after.
Sampling, sample size estimation, and randomisation
Abstinence Incentives for Methadone Maintained Stimulant Users: Outcomes for Those Testing Stimulant Positive vs Negative at Study Intake Maxine L. Stitzer.
Education 793 Class Notes Presentation 10 Chi-Square Tests and One-Way ANOVA.
WHS AP Psychology Research Methods: Experiments. I CAN ANSWER How do psychologists use the scientific method to study behavior and mental processes? What.
Educational Research Chapter 13 Inferential Statistics Gay, Mills, and Airasian 10 th Edition.
EXPERIMENTAL EPIDEMIOLOGY
1 Chapter 8 Introduction to Hypothesis Testing. 2 Name of the game… Hypothesis testing Statistical method that uses sample data to evaluate a hypothesis.
ITEC6310 Research Methods in Information Technology Instructor: Prof. Z. Yang Course Website: c6310.htm Office:
Causal relationships, bias, and research designs Professor Anthony DiGirolamo.
Objectives To understand the difference between parametric and nonparametric Know the difference between medically and statistically significant Understand.
Stats Lunch: Day 3 The Basis of Hypothesis Testing w/ Parametric Statistics.
ANCOVA.
Summary: connecting the question to the analysis(es) Jay S. Kaufman, PhD McGill University, Montreal QC 26 February :40 PM – 4:20 PM National Academy.
The parametric g-formula and inverse probability weighting
Educational Research Inferential Statistics Chapter th Chapter 12- 8th Gay and Airasian.
(ARM 2004) 1 INNOVATIVE STATISTICAL APPROACHES IN HSR: BAYESIAN, MULTIPLE INFORMANTS, & PROPENSITY SCORES Thomas R. Belin, UCLA.
PH240A Epidemiology and the Curse of Dimensionality Alan Hubbard Division of Biostatistics U.C. Berkeley
Uses of Diagnostic Tests Screen (mammography for breast cancer) Diagnose (electrocardiogram for acute myocardial infarction) Grade (stage of cancer) Monitor.
STA248 week 121 Bootstrap Test for Pairs of Means of a Non-Normal Population – small samples Suppose X 1, …, X n are iid from some distribution independent.
Harvard T.H. Chan School of Public Health
Statistical Core Didactic
Sec 9C – Logistic Regression and Propensity scores
Simulation: Sensitivity, Bootstrap, and Power
Presenter: Wen-Ching Lan Date: 2018/03/28
Issues in Hypothesis Testing in the Context of Extrapolation
Longitudinal Analysis Beyond effect size
Research Techniques Made Simple: Interpreting Measures of Association in Clinical Research Michelle Roberts PhD,1,2 Sepideh Ashrafzadeh,1,2 Maryam Asgari.
Yu Du, PhD Research Scientist Eli Lilly and Company
Presentation transcript:

Assessing ETA Violations, and Selecting Attainable/Realistic Parameters Causal Effect/Variable Importance Estimation and the Experimental Treatment Assumption

The Need for Experimentation Estimation of Variable Importance/Causal Effect requires assumption not needed for prediction “Experimental Treatment Assignment” (ETA) –Must be some variation in treatment variable A within every stratum of confounders W W must not perfectly predict/determine A g(a|W)>0 for all (a,W)

ETA Violations Ex #1: Some treatment histories perfectly predict presence of a given mutation Ex #2: Certain types of individuals never receive once daily therapy ETA violations imply lack of identifiability for variable importance/ causal effect –Reliance on extrapolation –Can lead to serious bias in estimates

Diagnostic for ETA Bias Inverse Probability of Treatment Weighted (IPTW) estimators rely completely on ETA –Don’t extrapolate, unlike MLE or T-MLE Diagnostic tool available to quantify the extent of bias in IPTW estimators due to ETA violations –Relies on parametric bootstrap Serves to quantify extent to which ψ is not identifiable –i.e. Extent to which T-MLE estimate relies on extrapolation

Example: Causal Effect of Adherence Interventions Goal: Estimate the causal effect of a point treatment –Intervention (A) aimed to improve adherence to antiretroviral drugs A 1 =use of a pill box organizer A 2 =use of once daily therapy –Outcome (Y) = % of prescribed doses taken What is the effect of pill boxes/once daily therapy on adherence?

Example: Parameter of Interest Confounding by a range of covariates W –Include: past treatment history, clinical characteristics, socioeconomic variables –E.g. crack users may be less likely to use pill boxes and also less likely to adhere Parameter of Interest: –Difference in expected adherence if whole population had used the intervention E(Y 1 ) vs. if whole population had not used it E(Y 0 )

Example: Parameter of Interest Parameter of Interest: E(Y 1 )-E(Y 0 ) If assume no unmeasured confounders (W sufficient to control for confounding) Causal Effect is same as W-adjusted Variable Importance E(Y 1 )-E(Y 0 )=E[E(Y|A=1,W)-E(Y|A=0,W)]= ψ –Same advantages to T-MLE

Example: Pill Box Adherence Effect estimates suggest pill box organizers improve adherence, but one daily therapy does not However… ETA diagnostic suggests effect of once daily therapy not identifiable from the data –Can’t adjust for confounders that are perfect predictors –Ex. No Latina women received once daily therapy –Ex. Some type of regimens not available as once daily therapy –Can’t conclude no effect for once daily therapy

Example: ETA Bias in the Estimated Effect of Adherence Interventions 850%0% higher adherence (95% CI: -6%-14%) Once Daily Therapy 0.01%4% higher adherence (95%CI:1%-7%) Pill Box Organizer Relative ETA Bias in IPTW Estimate T-MLE Effect EstimateIntervention

ETA Violations May Be More than a Nuisance Goal: Estimate the causal effect of a longitudinal treatment on outcome Some subjects, over the course of follow-up, develop contraindications to the treatment What is the real parameter of interest? –Randomized trial in which everyone (even those who develop contraindications) forced to comply with longitudinal assigned treatment –Randomized trial in which those who develop contra- indications over the course of the trial not forced to comply

Realistic Causal Effect of Point Treatment Intervention ψ = E{E[Y|A=d(1)(W),W]-E[Y|A=d(0)(W),W]} –d(1)(W)= { a=1 if g(1|W)>α; a=0 otherwise} –d(0)(W)= { a=0 if g(0|W)>α; a=1 otherwise} Similar to Intent-to-Treat analysis –Estimates effect of randomly assigning the intervention, –But… accepts that some individuals may not be able to comply with the regimen to which they are assigned Targeted MLE estimators available

Simulation Result: Realistic vs. Truncation of Weights for IPTW Data Generation- A is confounded, with ETA violations – W=Uniform(-5,5); p=1/(1+e *W ); A=Binomial(p) –No causal effect of A: Y= 2+4W 2 +N(0,1) –Simulation run 5000 times for each sample size N=50N=100N=250N=500N=1000 Naïve IPTW IPTW MSE IPTW-Truncated Weight IPTW-Truncated Weight MSE IPTW-REAL IPTW-REAL MSE

Example: HIV resistance mutations Goal: Rank a set of genetic mutations based on their importance for determining an outcome –Mutations (A) in the HIV protease enzyme Measured by sequencing –Outcome (Y) = change in viral load 12 weeks after starting new regimen containing saquinavir How important is each mutation for viral resistance to this specific protease inhibitor drug? –Inform genotypic scoring systems

Example: Parameter of Interest Need to control for a range of other covariates W –Include: past treatment history, baseline clinical characteristics, non-protease mutations, other drugs in regimen Parameter of Interest: Variable Importance ψ = E[E(Y|A j =1,W)-E(Y|A j =0,W)] –For each protease mutation (indexed by j)

Unadjusted estimates

Fully adjusted estimates

Delta-adjusted estimates

Summary Variable Importance/Causal Effect estimates rely on sufficient experimentation (ETA) for identifiability –Diagnostic tool available to diagnose ETA problems Realistic an Delta-Variable Importance/Causal Effect ensures parameter is identifiable, even with ETA violations –Realistic is often parameter of interest –In general, realistic provides test of null hypothesis for standard variable importance/causal effect ETA problems can also be avoided by selecting the appropriate adjustment set data-adaptively.